Form 4 for PCVX Vaxcyte, Inc.
Accepted 2025-01-17 00:00:00 ET · period of report 2025-01-15 · accession 0001649094-25-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-01-17 | 2025-01-15 | PCVX | Loxam Teri | Dir | S - Sale+OE | $85.11 | -6,250 | 10.7K | -37% | -$532.0K |
| D | 2025-01-17 | 2025-01-15 | PCVX | Loxam Teri | Dir | M - OptEx | $22.70 | +6,250 | 13.4K | +87% | +$141.9K |
| D | 2025-01-17 | 2025-01-15 | PCVX | Loxam Teri | Dir | M - OptEx | $0.00 | -6,250 | 6,250 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-15 | S | D | 1,043 | $85.29 | 9,683 | D | — | — | (F6) The price reported is a weighted-average price. The shares were sold at prices ranging from $84.83 to $85.73. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2025-01-15 | S | D | 966 | $86.26 | 8,717 | D | — | — | (F7) The price reported is a weighted-average price. The shares were sold at prices ranging from $85.89 to $86.59. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2025-01-15 | M | A | 6,250 | $22.70 | 13,425 | D | — | — | |
| 4 | Common | Common Stock | 2025-01-15 | S | D | 1,013 | $87.38 | 7,704 | D | — | — | (F8) The price reported is a weighted-average price. The shares were sold at prices ranging from $86.89 to $87.75. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 5 | Common | Common Stock | 2025-01-15 | S | D | 529 | $88.54 | 7,175 | D | — | — | (F9) The price reported is a weighted-average price. The shares were sold at prices ranging from $87.915 to $88.91. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 6 | Common | Common Stock | 2025-01-15 | S | D | 146 | $80.46 | 13,279 | D | — | — | (F2) The price reported is a weighted-average price. The shares were sold at prices ranging from $80.32 to $80.48. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 7 | Common | Common Stock | 2025-01-15 | S | D | 215 | $81.53 | 13,064 | D | — | — | (F3) The price reported is a weighted-average price. The shares were sold at prices ranging from $81.36 to $81.735. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 8 | Common | Common Stock | 2025-01-15 | S | D | 1,136 | $82.89 | 11,928 | D | — | — | (F4) The price reported is a weighted-average price. The shares were sold at prices ranging from $82.455 to $83.42. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 9 | Common | Common Stock | 2025-01-15 | S | D | 1,202 | $83.93 | 10,726 | D | — | — | (F5) The price reported is a weighted-average price. The shares were sold at prices ranging from $83.51 to $84.37. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 10 | Derivative | Stock Option (right to buy) | 2025-01-15 | M | D | 6,250 | $0.00 | 6,250 | D | $22.70 · — to 2032-05-31 | 6,250 Common Stock | (F10) Option is fully vested and exercisable. |